Can a screening programme for diabetes be applied to another population?

Diabetic Medicine

Volumn 22, Issue 9, 2005, Pages 1234-1238

  Glümer, Charlotte ^a,b   Borch Johnsen, K ^a   Colagiuri, S ^c  

^a STENO DIABETES CENTER   (Denmark)

^b GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Diabetes; Evaluation; Fasting plasma glucose; Risk score; Screening

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; AUSTRALIA; CAUCASIAN; CLINICAL PROTOCOL; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; SCREENING TEST; SENSITIVITY AND SPECIFICITY;

ADULT; AUSTRALIA; BLOOD GLUCOSE; BODY MASS INDEX; CLINICAL PROTOCOLS; COHORT STUDIES; DENMARK; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; PREVALENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 24044475238     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01641.x     Document Type: Article

References (19)

1. Engelgau MM, Narayan KMV, Herman WH. Screening for type 2 diabetes. Diabetes Care 2000; 23: 1563-1580.
2. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
3. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99.2. Geneva: World Health Organisation, 1999.
4. American Diabetes Association. American diabetes alert. Diabetes Forecast 1993; 46: 54-55.
5. Herman WH, Smith PJ, Thompson TJ, Engelgau MM, Aubert RE. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care 1995; 18: 382-387.
6. Ruige JB, de Neeling JN, Kostense PJ, Bouter LM, Heine RJ. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. Diabetes Care 1997; 20: 491-496.
7. Baan CA, Ruige JB, Stolk RP, Witteman JC, Dekker JM, Heine RJ et al. Performance of a predictive model to identify undiagnosed diabetes in a health care setting. Diabetes Care 1999; 22: 213-219.
8. Lindstrom J, Tuomilehto J. The Diabetes Risk Score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003; 26: 725-731.
9. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000; 16: 164-171.
10. Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004; 27: 727-733.
11. Glumer C, Jorgensen T, Borch-Johnsen K. Prevalences of diabetes and impaired glucose regulation in a Danish population: the Inter99 study. Diabetes Care 2003; 26: 2335-2340.
12. Dunstan DW, Zimmet PZ, Welborn TA, de-Courten M, Cameron AJ, Sicree RA et al. The rising prevalence of diabetes and impaired glucose tolerance. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829-834.
13. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-577.
14. Drivsholm T, Ibsen H, Schroll M, Davidsen M, Borch-Johnsen K. Increasing prevalence of diabetes mellitus and impaired glucose tolerance among 60-year-old Danes. Diabet Med 2001; 18: 126-132.
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003; 26: 3160-3167.
16. Borch-Johnsen K, Colagiuri S, Balkau B, Glumer C, Carstensen B, Ramachandran A et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia 2004; 47: 1396-1402.
17. Spijkerman A, Griffin S, Dekker J, Nijpels G, Wareham NJ. What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective. J Med Screen 2002; 9: 187-190.
18. Tabaei BP, Herman WH. A multivariate logistic regression equation to screen for diabetes: development and validation. Diabetes Care 2002; 25: 1999-2003.
19. Spijkerman AM, Yuyun MF, Griffin SJ, Dekker JM, Nijpels G, Wareham NJ. The performance of a risk score as a screening test for undiagnosed hyperglycemia in ethnic minority groups: data from the 1999 health survey for England. Diabetes Care 2004; 27: 116-122.